April 9, 2021 -- InvestorsHub NewsWire -- via AmericanBulls.com/ALKM -- UPDATE To
Earlier AmericanBulls.com/ALKM
ALKM stockchart (stockchart.com/ALKM) shows PPS breaking out above 50
day moving average (MA) and an MACD cross in process.
Our system’s recommendation today is
to BUY. The BULLISH HARAMI
CROSS pattern finally received a confirmation because the
prices crossed above the confirmation level which was at 0.0025,
and our valid average buying price stands now at 0.0030.
he green light is on and this security is now
screaming BUY. It is action time! The bullish
pattern that was previously identified is finally confirmed and
a BUY signal is generated. Most
probably, it is the right time to participate in bullish fervor. Do
not miss this bullish opportunity.
From the Digital Journal on ALKM
Recent Consolidation In Alkame Holdings, Inc. Share Price Sets
The Stage For A Technical Breakout (ALKM)
Alkame Holdings, Inc. (OTCPINK: ALKM) shares completed March by
consolidating at the $0.0026 level. The great news is that with the
stock still up roughly 116% since the start of February, investors
appeared only willing to give back a tiny part of its YTD run. That
could be good news heading into April, and with ALKM positioned to
benefit from several potentially lucrative agreements, the stock
could move higher on several updates.
Investors are already focused on how recent deals made through
its wholly-owned subsidiary West Coast Co-Packer, Inc., can impact
ALKM's growth. Several deals were announced since 2021. The most
recent has West Coast Co-Packer, Inc. entering a development and
production agreement with Shmellins Market, LLC. to develop and
beta test consumer products. Shmellins is an emerging consumer
products company that could provide substantial business to West
Coast. The initial agreement leverages West Coast's logistics
expertise to extend Shmellin's product reach. The deal is a
win-win.
Notably, that deal is one of three made by West Coast Co-Packer
this year.
Handout Protection Sanitizer
A potentially significant and long-term deal was announced in
February when ALKM said West Coast Co-Packer received an initial
purchase order for Handout Protection hand
sanitizer and wash combo single-use packets. The agreement was made
through their Canadian Personal Protection Equipment (PPE)
distributor, TheraProducts Canada, Inc., and could become a
long-term value driver for ALKM by capitalizing on that product's
potential best-in-class COVID-19 bacteria-killing
ability.
Moreover, the recent decline in COVID-19 cases has little
bearing on the potential of the product. In fact, Handout
Protection could become a staple item for consumers by
showing effectiveness in killing known COVID-19 strains and the new
coronavirus variants known to spread 50% quicker than COVID-19.
It's also important to note that it's also one of the few portable
hand wash and sanitizer packets that allow people to wash and
sanitize their entire hand.
Better still, it meets the needs of medical professionals by
enabling users to clean their palms and the tops and sides of the
hands, including the fingers, under the nails, and up to the wrist
to fight and kill bacteria and germs. And, even as the pandemic
gets put under control, it's unlikely that demand for effective
sanitizing and germ-killing products will decline. That's excellent
news for ALKM...and could be a massive driver in 2021.
Other deals are in place. And those agreements could add to the
333% YTD gains in the stock price.
Co-Packing Agreements Drive Expected Revenue
Growth
In March, it was announced that ALKM will be the co-packer for
Pao Group, Inc's (OTC Pink: PAOG) CBD RELAX-RX nutraceutical
product. News of that deal sent shares soaring, with investors
evaluating the impact that drug could have on generating revenues
for ALKM. It will be, after all, targeting the massive anxiety and
depression market.
It's also CBD-related, and despite a rotation out of the sector
by institutional money in Q1, it appears that money is flowing back
toward these stocks as the new quarter begins. For PAOG and ALKM,
the rewards can be substantial. And even earning a piece could
create exponential gains for each stock. As noted, CBD RELAX-RX
targets an anxiety and depression treatment market, which is
expected to become a more than $18 billion market opportunity by
2025. At current market levels, the market is still enormous,
estimated to be a roughly $10 billion segment where demand for
better and safer standards of care is high.
Notably, CBD-based therapeutics is proving that it can offer
similar or better relief than current pharmaceuticals that often
have severe side effects. The excellent news is that the two are
making progress in getting treatment to market.
Alkame is also a part of PAOG's other promising CBD-based
therapeutic, RexpRx. Targeting another massive market opportunity,
CBD-based RespRx targets treating issues associated with Chronic
Obstructive Pulmonary Disorder (COPD). The commercialization of
that product, which PAOG expects can happen this year, puts a
catalyst in play that could drive ALKM valuations substantially
higher.
Other programs are advancing as well. The company's progress in
its proprietary functional water technology is also adding value.
There, ALKM announced it has streamlined and improved its water
manufacturing processes, resulting in fluoride-free, alkaline water
with a lower oxidation-reduction potential (ORP) and its
highest-ever oxygen content. The result is a "good-for-you" water
that has been shown to aid in lactate clearance after exercise,
toxin removal, and decreased recovery times. That program could
offer new revenue streams through licensing, partnership, and joint
venture strategies.
Best of all, each program can be quickly accretive to revenues.
And with a strong consolidation at current prices, the stock could
be set technically to break higher on company news. Still,
investors should focus on ALKM's co-packing relationship with
Puration, Inc. (OTC Pink: PURA), the marketer
of EVERx CBD-based water.
That deal could be the most near-term value-driver. And a
quarterly update from PURA could raise expectations for ALKM's
benefit in 2021.
Partnerships Bringing Value
The co-packing deal with PURA can be significant. ALKM, again
through its wholly-owned subsidiary, West Coast Co-Packer, Inc.,
has announced an expansion of current agreements with Puration,
Inc. to enhance its services as the bottler of EVERx
CBD-infused Sports Water. That product, by the way, is
already earning market share, with PURA announcing that sales
of EVERx CBD-infused sports water should surpass
$2 million in 2020. Additional growth in 2021 is also expected.
Growth for PURA inherently translates to growth for ALKM. Thus,
investors should pay attention to that company's imminent financial
update.
Better still, beyond bottling EVERx, ALKM is enhancing the PURA
partnership and is collaborating to bring to market multiple new
CBD-infused consumer products, including a CBD-infused liquid sugar
and a CBD pet food supplement. Other products in the development
stages include CBD-infused consumer products and hemp-derived
beverages and edibles. Any, or even all, of these products, could
be met with substantial consumer demand. Undoubtedly, CBD-based
products are flying off the shelves as the compound continues to
show extraordinary benefit to patients suffering from a number of
conditions.
Best of all, with ALKM having the logistical support in place
for PURA to expedite the market launch of new products, additional
revenues could support the expected rise in sales of EVERx. For
ALKM, a product win for PURA is a product win for them. Thus, with
multiple shots on product goal, 2021 sets itself to be a
potentially transformative year. That means that buying at these
levels could translate into exponentially higher prices if new
products earn traction. Even passing milestones in testing could
add near-term value to each.
And while the focus is on ALKM's partnerships, investors should
take time to evaluate the intrinsic value offered through ALKM's
more than ten subsidiaries. Those assets strengthen the investment
proposition by showing ALKM is vested in multiple programs through
a diversified products portfolio. For investors, those subsidiaries
not only mitigate risk but also create additional
opportunities.
And with the pandemic seemingly under control with CBD becoming
more popular by the day, ALKM may be in its best position ever to
maximize its opportunities. Thus, at current prices that barely
factor in its value as the EVERx bottler, a massive opportunity may
be exposed that can exchange near-term ALKM milestones into
long-term financial gains.
And in any investor's playbook, that is usually an ideal
scenario to seize.
Disclaimers: Hawk Point Media is responsible for the
production and distribution of this content. Hawk Point Media is
not operated by a licensed broker, a dealer, or a registered
investment adviser. It should be expressly understood that under no
circumstances does any information published herein represent a
recommendation to buy or sell a security. Our reports/releases
are a commercial advertisement and are for general information
purposes ONLY. We are engaged in the business of marketing and
advertising companies for monetary compensation. Never invest in
any stock featured on our site or emails unless you can afford to
lose your entire investment. The information made available by
Hawk Point Media is not intended to be, nor does it constitute,
investment advice or recommendations. The contributors may buy and
sell securities before and after any particular article, report and
publication. In no event shall Hawk Point Media be liable to any
member, guest or third party for any damages of any kind arising
out of the use of any content or other material published or made
available by Hawk Point Media, including, without limitation, any
investment losses, lost profits, lost opportunity, special,
incidental, indirect, consequential or punitive damages. Hawk Point
Media was compensated three-thousand-five-hundred-dollars by wire
transfer to produce research, video, email, newsletters, and
editorial commentary for Alkame Holdings, Inc. by a third party.
Past performance is a poor indicator of future performance. The
information in this video, article, and in its related newsletters,
is not intended to be, nor does it constitute, investment advice or
recommendations. Hawk Point Mediastrongly urges you conduct a
complete and independent investigation of the respective companies
and consideration of all pertinent risks. Readers are advised to
review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider
reports, Forms 3, 4, 5 Schedule 13D
The Private Securities Litigation Reform Act of 1995
provides investors a safe harbor in regard to forward-looking
statements. Any statements that express or involve discussions with
respect to predictions, expectations, beliefs, plans, projections,
objectives, goals, assumptions or future events or performance are
not statements of historical fact may be forward looking
statements. Forward looking statements are based on expectations,
estimates, and projections at the time the statements are made that
involve a number of risks and uncertainties which could cause
actual results or events to differ materially from those presently
anticipated. Forward looking statements in this action may be
identified through use of words such as projects, foresee, expects,
will, anticipates, estimates, believes, understands, or that by
statements indicating certain actions & quote; may, could, or
might occur. Understand there is no guarantee past performance will
be indicative of future results.Investing in micro-cap and growth
securities is highly speculative and carries an extremely high
degree of risk. It is possible that an investors investment may be
lost or impaired due to the speculative nature of the companies
profiled.
Media Contact
Company Name: Hawk Point Media
Contact Person: KL Feigeles
Email: Send
Email
City: Miami Beach
State: Florida
Country: United States
Website: https://www.greenlightstocks.com
Read more: http://www.digitaljournal.com/pr/5025036#ixzz6rXbIb0M7
Other stocks on the move include RGBP, and
INND
SOURCE: AmericanBulls.com/ALKM
Innerscope Hearing Techn... (PK) (USOTC:INND)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025
Innerscope Hearing Techn... (PK) (USOTC:INND)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025
